New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on August 26, 2026

Aug. 26, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

Aug. 26, 2026

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent

Indeterminate GlobeNewswire

Aug. 26, 2026

FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development

Indeterminate GlobeNewswire

Aug. 26, 2026

CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities

Indeterminate GlobeNewswire

Aug. 26, 2026

BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

Indeterminate GlobeNewswire

Aug. 26, 2026

Tvardi Therapeutics to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire

Aug. 26, 2026

Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

Aug. 26, 2026

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 26, 2026

InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference

Indeterminate GlobeNewswire

Aug. 26, 2026

Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers

Indeterminate GlobeNewswire

Aug. 26, 2026

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire

Aug. 26, 2026

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

Aug. 26, 2026

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Indeterminate GlobeNewswire

Aug. 26, 2026

Eikon Therapeutics to Participate in Investor Conferences in September 2026

Indeterminate GlobeNewswire

Aug. 26, 2026

MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia

Indeterminate GlobeNewswire

Aug. 26, 2026

Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI

Indeterminate GlobeNewswire

Aug. 26, 2026

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

Indeterminate GlobeNewswire

Aug. 26, 2026

Ligand to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Aug. 26, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

Indeterminate GlobeNewswire

Aug. 26, 2026

Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines

Indeterminate GlobeNewswire